Author:
Koklesova Lenka,Liskova Alena,Samec Marek,Qaradakhi Tawar,Zulli Anthony,Smejkal Karel,Kajo Karol,Jakubikova Jana,Behzadi Payam,Pec Martin,Zubor Pavol,Biringer Kamil,Kwon Taeg Kyu,Büsselberg Dietrich,Sarria Gustavo R.,Giordano Frank A.,Golubnitschaja Olga,Kubatka Peter
Abstract
AbstractSevere durable changes may occur to the DNA structure caused by exogenous and endogenous risk factors initiating the process of carcinogenesis. By evidence, a large portion of malignancies have been demonstrated as being preventable. Moreover, the targeted prevention of cancer onset is possible, due to unique properties of plant bioactive compounds. Although genoprotective effects of phytochemicals have been well documented, there is an evident lack of articles which would systematically present the spectrum of anticancer effects by phytochemicals, plant extracts, and plant-derived diet applicable to stratified patient groups at the level of targeted primary (cancer development) and secondary (cancer progression and metastatic disease) prevention. Consequently, clinical implementation of knowledge accumulated in the area is still highly restricted. To stimulate coherent co-development of the dedicated plant bioactive compound investigation on one hand and comprehensive cancer preventive strategies on the other hand, the current paper highlights and deeply analyses relevant evidence available in the area. Key molecular mechanisms are presented to detail genoprotective and anticancer activities of plants and phytochemicals. Clinical implementation is discussed. Based on the presented evidence, advanced chemopreventive strategies in the context of 3P medicine are considered.
Funder
Universitätsklinikum Bonn
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry (medical),Health Policy,Drug Discovery
Cited by
62 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献